These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36090997)

  • 1. Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4
    Inderbitzin A; Loosli T; Opitz L; Rusert P; Metzner KJ
    Front Immunol; 2022; 13():915805. PubMed ID: 36090997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir.
    Neidleman J; Luo X; Frouard J; Xie G; Hsiao F; Ma T; Morcilla V; Lee A; Telwatte S; Thomas R; Tamaki W; Wheeler B; Hoh R; Somsouk M; Vohra P; Milush J; James KS; Archin NM; Hunt PW; Deeks SG; Yukl SA; Palmer S; Greene WC; Roan NR
    Elife; 2020 Sep; 9():. PubMed ID: 32990219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
    White CH; Moesker B; Beliakova-Bethell N; Martins LJ; Spina CA; Margolis DM; Richman DD; Planelles V; Bosque A; Woelk CH
    PLoS Pathog; 2016 Nov; 12(11):e1006026. PubMed ID: 27898737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions.
    Zhang X; Qazi AA; Deshmukh S; Lobato Ventura R; Mukim A; Beliakova-Bethell N
    Front Cell Infect Microbiol; 2023; 13():1286168. PubMed ID: 38156317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
    Lee WS; Richard J; Lichtfuss M; Smith AB; Park J; Courter JR; Melillo BN; Sodroski JG; Kaufmann DE; Finzi A; Parsons MS; Kent SJ
    J Virol; 2016 Feb; 90(4):2021-30. PubMed ID: 26656700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
    de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
    Front Immunol; 2021; 12():720697. PubMed ID: 34531866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
    Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC
    PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.
    Dalecki AG; Greer BD; Duverger A; Strange EL; Carlin E; Wagner F; Shi B; Lowman KE; Perez M; Tidwell C; Kaczmarek Michaels K; Giattina S; Bossmann SH; Henderson AJ; Hu H; Kutsch O
    J Virol; 2022 Mar; 96(5):e0197421. PubMed ID: 35019721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combination of Venetoclax and Ixazomib Selectively and Efficiently Kills HIV-Infected Cell Lines but Has Unacceptable Toxicity in Primary Cell Models.
    Alto A; Natesampillai S; Chandrasekar AP; Krogman A; Misra A; Shweta F; VanLith C; Yao JD; Cummins NW; Badley AD
    J Virol; 2021 May; 95(12):. PubMed ID: 33827940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.
    Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
    Iglesias-Ussel M; Vandergeeten C; Marchionni L; Chomont N; Romerio F
    J Virol; 2013 Aug; 87(16):9148-58. PubMed ID: 23760244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Novel
    Wong ME; Johnson CJ; Hearps AC; Jaworowski A
    J Virol; 2021 Sep; 95(19):e0022721. PubMed ID: 34287050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.